Observational studyRheumatology (Oxford, England)2026
Vaccination rates in rheumatic diseases: a cross-sectional register study on the role of patient beliefs and physician engagement.
Observational study in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vaccination considerations in autoimmune rheumatic diseases.Nature reviews. Rheumatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesTo evaluate the vaccination attitude and behaviour of patients with autoimmune inflammatory rheumatic diseases (AIIRD), and identify factors associated with vaccination status, utilizing data from a national register.
methodsA cross-sectional survey was developed to assess behaviour around vaccination of patients with AIIRD, nested within the Swiss Clinical Quality Management (SCQM) register. The primary outcome was vaccination uptake evaluated through three parameters: checking vaccination status (i.e. ensuring that vaccinations were checked by a health professional), influenza and pneumococcal vaccination coverage. The main exposure evaluated was patient's beliefs about vaccination importance and safety. Vaccination uptake was analysed using descriptive statistics, and associations with exposures using logistic regression. Missing data were imputed by multiple imputation, and multivariable analyses were adjusted for age, gender, body mass index, disease type, disease duration, treatment.
resultsOf 2446 patients (59% women, 79% <65 years old) included, 52% believed in both the importance and safety of vaccine and 2% believed both that vaccination was neither safe nor important. Most patients (64%) reported no change in their vaccination beliefs after the COVID-19 pandemic. Among respondents, 48% had checked their vaccination status in the past 24 months, 51% reported vaccination against influenza and 33% against pneumococcal pneumonia. Discussions with the rheumatologist about vaccination during follow-up or before initiating treatment were positively associated with vaccination.
conclusionVaccination uptake was relatively low in this vulnerable population. Strategies promoting discussion with the rheumatologist about vaccination and before treatment could play a pivotal role in improving vaccination uptake among patients with AIIRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.